Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Bringing Hope to People Living with Neurodegenerative Diseases

Alpha Cognition Inc. ( TSX-V.ACOG , OTCMKTS: ACOGF , Forum ) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases. Stockhouse Media’s Dave Jackson caught up recently with Company CE...
Dave Jackson | October 20, 2021 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Buzz on the Bullboards: Rebound, or smoke and mirrors?

Could the recent fears around banking stocks be washing away? Given the recent performance among major indices, it seems possible. Gold held steady as the usual investment haven and that played right into the hands of miners ready with fresh news. Reaping the fr...
Jonathon Brown | March 23, 2023 |

Next-generation augmented reality wayfinding for the real-world metaverse

Hello and welcome to The Market Herald, I’m Daniella Atkinson, and this is The Topline. ARWay Corporation is engaged in developing and operating the ARway mobile app. ARWay is an all-in-one, no-code, real-world Metaverse creation tool with self-generat...
Daniella Atkinson | December 21, 2022 |

Profiting from Protection: The Power of Permission-Based Partner Programs

(Click image to play podcast) Savvy investors know that lot of smart money is now funnelling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation. ...
Dave Jackson | August 28, 2020 |

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...
Streetwise Reports | May 28, 2020 |

Campbell Soup Earnings Are Good Food for Investors

Now serving much more than just soup, shares of multi-brand food conglomerate Campbell Soup Co. are trading 10% higher today as the firm announced better than expected annual earnings. Shares of Campbell Soup Company (CPB:NYSE) are trading more than 10% higher today...
Streetwise Reports | September 3, 2019 |

Electromed Earnings Spark a 25% Increase in Its Share Price

Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. Develo...
Streetwise Reports | November 14, 2019 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |

Buzz on the Bullboards: PyroGenesis, Antibe Top All Sectors

The reign of COVID-19 related gains is over on the Stockhouse Bullboards. Instead, the new king comes from the unlikeliest of sectors: Industrials. Of course, it’s not surprising to have a profitable and quickly rising small-cap company in the industrials s...
Omri Wallach | June 17, 2020 |
1 2 3 4 5 6 7 8 9 10 ...